Next Article in Journal
Production of Exopolysaccharides by Cultivation of Halotolerant Bacillus atrophaeus BU4 in Glucose- and Xylose-Based Synthetic Media and in Hydrolysates of Quinoa Stalks
Next Article in Special Issue
The Technological Perspectives of Kombucha and Its Implications for Production
Previous Article in Journal
Antimicrobial Activity of Zymomonas mobilis Is Related to Its Aerobic Catabolism and Acid Resistance
Previous Article in Special Issue
Differentiation of Penicillium roqueforti from Closely Related Species Contaminating Cheeses and Dairy Environment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in Fermentation Products

Sciensano, Biological Health Risk, Transversal Activities in Applied Genomics (TAG), Rue Juliette Wytsman 14, 1050 Brussels, Belgium
*
Author to whom correspondence should be addressed.
Fermentation 2022, 8(2), 78; https://doi.org/10.3390/fermentation8020078
Submission received: 13 January 2022 / Revised: 9 February 2022 / Accepted: 10 February 2022 / Published: 12 February 2022
(This article belongs to the Special Issue Contamination of Fermentation Systems and Methods of Control)

Abstract

:
Most of the bacteria that are used to produce fermentation products, such as enzymes, additives and flavorings, belong to the Bacillus subtilis group. Recently, unexpected contaminations with unauthorized genetically modified (GM) bacteria (viable cells and associated DNA) that were carrying antimicrobial resistance (AMR) genes was noticed in several microbial fermentation products that have been commercialized on the food and feed market. These contaminations consisted of GM Bacillus species belonging to the B. subtilis group. In order to screen for the potential presence of such contaminations, in this study we have developed a new real-time PCR method targeting the B. subtilis group, including B. subtilis, B. licheniformis, B. amyloliquefaciens and B. velezensis. The method’s performance was successfully assessed as specific and sensitive, complying with the Minimum Performance Requirements for Analytical Methods of GMO Testing that is used as a standard by the GMO enforcement laboratories. The method’s applicability was also tested on 25 commercial microbial fermentation products. In addition, this method was developed to be compatible with the PCR-based strategy that was recently developed for the detection of unauthorized GM bacteria. This taxon-specific method allows the strengthening of the set of screening markers that are targeting key sequences that are frequently found in GM bacteria (AMR genes and shuttle vector), reinforcing control over the food and feed chain in order to guarantee its safety and traceability.

1. Introduction

Genetically modified microorganisms (GMM) are commonly used by the food and feed industries in order to produce microbial fermentation products, including enzymes, additives and flavorings. Since 2014, several unexpected contaminations with GMM, both viable strains and their associated DNA, in microbial fermentation products that were commercialized on the European (EU) food and feed chain were observed, leading to numerous RASFF (Rapid Alert System for Food and Feed) notifications according the EC/2003/1830 regulation [1,2,3,4,5,6,7,8,9,10,11,12,13,14]. In addition, such GMM are frequently carrying antimicrobial resistance (AMR) genes as a selection marker [5,6,7,8,9,10,11,12,15]. Consequently, health concerns that are related to the presence of AMR genes in the food and feed chain were raised regarding the horizontal transfers of AMR genes to pathogens and gut microbiota, resulting in treatment failure [16,17,18,19,20]. Therefore, to ensure the safety and traceability of the food and feed chain as well as the freedom of the consumer’s choice, the control of GMM contaminations in microbial fermentation products was demanded by the competent authorities [4,5,6,7,8,9,10,11,12].
The current strategy that has been implemented by enforcement laboratories in order to control genetically modified organisms (GMO) in the food and feed chain is mainly targeting genetically modified (GM) plants. This strategy is composed of two main successive steps using real-time PCR methods. More precisely, a first-line screening analysis step, one that is targeting the taxon-specific markers and genetic elements that are commonly found in GM plants, is applied in order to screen for the potential presence of GM plants. A second-line analysis step is then applied in order to identify the specific GM plant events in targeting their unique junctions between the host genome and the transgenic cassette. The second-line methods are provided by the GM plant developer companies [21,22,23]. However, in order to control GMM contaminations, all of the sequences that are related to GMM are confidential and, in contrast to the GM plants that are intended for human and animal consumption, no methods that are specific to GMM strains are provided by manufacturers to the enforcement laboratories, therefore hampering the the establishment of a similar workflow for GMM testing [5,6,7,8,9,10,11,12,15].
In order to overcome these issues, publicly available data from patents and scientific literature were recently used in order to develop a set of first-line screening real-time PCR methods targeting the genetic elements that are frequently found in the GM bacteria that are used to produce microbial fermentation products [5,6,7,9]. More precisely, these methods target three AMR genes, being cat (GenBank: NC_002013.1), aadD (GenBank: M19465.1) and tet-L (GenBank: D00946.1) conferring a resistance to chloramphenicol, kanamycin and tetracycline, respectively, as well as a shuttle vector pUB110 carrying aadD (GenBank: M19465.1) [5,6,7,9]. If at least one of these screening markers is detected, a potential GMM contaminations can be suspected. A second-line analysis step was also developed in order to prove the presence of specific GM bacterial strains using real-time PCR methods targeting their unnatural associations of sequences. These sequences, which are publicly unavailable, were previously characterized by sequencing the DNA that was extracted either from GM bacterial isolates or from commercial microbial fermentation products with GMM contaminations [3,8,9,10,11,13]. Currently, these second-line methods allow the identification of the GM Bacillus velezensis strain that produces protease, the GM B. amyloliquefaciens strain that produces alpha-amylase, the GM B. subtilis strain that produces vitamin B2 and the GM B. amyloliquefaciens strain that produces protease. All of these first- and second-line real-time PCR methods were developed in order to comply with the Minimum Performance Requirements for Analytical Methods of GMO Testing of the European Network of GMO Laboratories, being used as a standard in GMO enforcement laboratories [5,6,7,9,24].
However, in contrast to the GM plant detection strategy, no taxon-specific method for GMM detection is currently available in the first-line screening analysis step. PCR-based methods, including real-time PCR and conventional PCR followed by sequencing, that are specific to key markers such as the bacterial genus (e.g., 16S-rRNA gene) [25,26] and bacterial species of interest (e.g., B. subtilis, B. licheniformis) [12,27,28,29,30] do exist. Nonetheless, the real-time PCR technology is usually preferred as it has been widely mastered by enforcement laboratories which are controlling GMO. Given that the enforcement laboratories carry out their analyses commonly under accreditation, the presently used real-time PCR methods should also comply with the Minimum Performance Requirements for Analytical Methods of GMO Testing of the European Network of GMO Laboratories. Moreover, in order to efficiently strengthen the GMM detection strategy, the taxon-specific method needs to be compatible with the set of methods that are used in the first-line screening analysis step (e.g., real-time PCR technology, TaqMan chemistry and PCR conditions) [5,6,7,9,24]. To this end, a taxon-specific real-time PCR method was developed in this study in order to target Bacillus species belonging to the B. subtilis group. More precisely, this B. subtilis group is composed in total of 10 closely related Bacillus species, including B. amyloliquefaciens, B. atrophaeus, B. licheniformis, B. mojavensis, B. pumilus, B. sonorensis, B. subtilis, B. tequilensis, B. vallismortis and B. velezensis. This screening method, named BSG, covers the majority of the GM bacterial species that have been reported as being used by the food and feed industry in order to produce microbial fermentation products, namely B. amyloliquefaciens, B. licheniformis, B. subtilis and B. velezensis [3,6,9,10,11,13,28,31,32,33]. The performance of the BSG method was assessed at the specificity and sensitivity levels, according the Minimum Performance Requirements for Analytical Methods of GMO Testing of the European Network of GMO Laboratories [24]. The applicability of the BSG method was also tested using several commercial microbial fermentation products. In addition, this taxon-specific method was designed to be compatible with the first-line screening analysis step of the GMM detection strategy. Therefore, by completing the set of real-time PCR screening methods, the BSG method can strengthen the control over GM bacterial contaminations in microbial fermentation products that are commercialized in the food and feed chain.

2. Materials and Methods

2.1. Materials

For the specificity and sensitivity assessments of the BSG method, DNA from the control plasmid (GeneCust, Boynes, France), artificially synthetized to carry one copy of the targeted sequence from B. subtilis, was used. DNA from Homo sapiens (G3041 Promega, Madison, WI, USA), Zea mays (ERM-BF413ak), wild-type microbial species and GM bacterial strains (B. subtilis RASFF2014.1249 and B. velezensis RASFF2019.333) were obtained as described in Table 1, Table 2 and Table 3 [5,6,7,8,9,10,11]. For the applicability assessment of the BSG method, DNA from several commercial microbial fermentation products (samples n°1–25) was obtained as described in Table 4. The presence of GMM contaminations was previously investigated in these samples [5,6,7,8,9,10,11]. The DNA’s concentration was measured by spectrophotometry using NanoDrop® 2000 (Thermo Fisher, Waltham, MA, USA) and the DNA’s purity was evaluated using the A260/A280 and A260/A230 ratios. The DNA concentration from the control plasmid was also measured by fluorometry using Qubit 3.0 Fluorometer (Thermo Fisher, Waltham, MA, USA). The DNA were also previously assessed as amplifiable [3,4,8,9,10,11].

2.2. Development and Validation of the BSG Method

Based on previous studies [28,30], the 16S-23S region was selected in order to develop a taxon-specific real-time-PCR method allowing the targeting of the B. subtilis group, including B. subtilis, B. licheniformis, B. amyloliquefaciens, B. pumilus and B. velezensis (Table 1) [28,30,32,33].
The targeted 16S-23S region from all of these species was aligned using the Clustal Omega software with the default parameters as well as a set of primers and a probe that was designed using the software Primer3. This taxon-specific real-time-PCR method, named BSG, was developed in order to be integrated into the first-line screening step of the current GMM detection strategy. Therefore, each real-time PCR assay was applied on a 25 µL reaction volume containing 1X TaqMan® PCR Mastermix (Diagenode, Liège, Belgium), 400 nM of each primer (Eurogentec, Liège, Belgium), 200 nM of the probe and 5 µL of DNA. The real-time PCR program consisted of a single cycle of DNA polymerase activation for 10 min at 95 °C followed by 45 amplification cycles of 15 sec at 95 °C (the denaturing step) and 1 min at 64 °C (the annealing–extension step). All of the runs were performed on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). A no template control (NTC) was included in each assay.

2.2.1. Specificity Assessment

First, an in silico analysis of the developed BSG method was performed using SCREENED v1.0 [34,35]. The parameter settings were maximum 10% of mismatches in the annealing site, minimum 90% of alignment length in the annealing site and no mismatch in the last five nucleotides at the 3′ end for the primers. This tool uses a two-step BLAST approach. First, the sequence(s) that were targeted by the developed BSG method were extracted from a dataset belonging to the NCBI Nucleotide RefSeq database (accessed on March 2021; filter: genome AND refseq AND complete). Subsequently, the hybridization properties of the targeted regions and the developed set of primers and probe were investigated. As the input for the BSG method, the sequences from the designed set of primers and probe and the expected amplicons that were generated from the targeted Bacillus species were used (Table 1 and Supplementary Tables S1 and S2).
Second, the developed BSG method was tested in triplicate on 10 ng of DNA from positive and negative controls (Table 2). For the positive controls, 24 wild-type strains belonging to B. amyloliquefaciens, B. licheniformis, B. pumilus, B. subtilis and B. velezensis as well as 2 GM strains corresponding to B. subtilis (RASFF2014.1249) and B. velezensis (RASFF2019.3332) were used. For the negative controls, 75 wild-type microbial strains belonging to fungal and bacterial species that are frequently used by the food and feed industry in order to produce microbial fermentation products were used. In addition, DNA from an animal (Homo sapiens) and a plant (Zea mays) was included.

2.2.2. Sensitivity Assessment

Serial dilutions of the DNA from the control plasmid carrying one copy of the targeted sequence from B. subtilis, going from 100 to 0.1 estimated target copy number, were prepared and each dilution point was tested in 12 replicates (Table 3).
The calculation of the estimated target copy number was based on the control plasmid size (2957 bp), as previously described [5,6,7,8,9,10,11]. The limit of detection LOD95%, defined as the number of copies of the target that were required to ensure a 95% probability of detection (POD), was determined by using the QuoData web application (Table S3). The plausibility check of the POD curve indicated no irregularities and that the POD curve was associated to a LOD95% below 25 estimated target copy numbers [24,36,37].

2.2.3. Applicability Assessment

Several commercial microbial fermentation products, including enzymes and additives, were used in order to evaluate the applicability of the developed BSG method (Table 4).
From each sample (n°1–25), 10 ng of the DNA was tested in duplicate (Table 4). These products (samples n°1–25) from different brands were labelled as containing vitamin B2, protease, alpha-amylase, cellulase, xylanase, beta-glucanase, transglutaminase, beta-glucosidase or rennet. These products, in liquid or solid forms, are intended for use in various sectors such as livestock farming, brewing, distillery, baking, diary processing, protein processing or fruit processing. The selection of these samples was performed based on the available information that was related to previously reported contaminations, allowing the present study to cover three possible scenarios (Table 4). First, as was observed with the samples n°1–18, the sample is contaminated by a known GMM, including the vitamin B2-producing GM B. subtilis strain, protease-producing GM B. velezensis strain, alpha-amylase-producing GM B. amyloliquefaciens strain and protease-producing GM B. amyloliquefaciens strain. Second, the sample is contaminated with bacterial DNA that is not related to the currently known GM bacterial strains. Based on previously obtained results, the samples n°19–22 were selected for this scenario as presenting a positive signal for the 16S-rRNA marker and a negative signal for the second-line methods targeting the currently known GM strains. Third, the sample is not contaminated with bacterial DNA, as was observed for the samples n°23–25 for which no positive signal for the 16S-rRNA marker was previously observed.

2.3. Illustration of the Reinforcement of the First-Line Screening Analysis Step Using the BSG Method

Few commercial microbial fermentation products (samples n°2–4, 6, 19–20, 22, 25) that are described in Table 4 were used in order to illustrate the reinforcement of the GMM detection strategy by completing the set of first-line screening methods with the BSG method (Table 5).
The results for the BSG method that were generated in this study are as described in the Section 2.2, while the results for the cat, tet-l, aadD and pUB110 methods were previously generated [4,8,9,10,12].

3. Results and Discussion

3.1. Development of the BSG Method

Among the 37 GM bacterial strains that have been reported as being used by the food and feed industry to produce enzymes, additives and flavoring, 75.6% of them belong to the B. licheniformis and B. subtilis species [6,31]. These two bacterial species belong to the B. subtilis group, which is composed in total of 10 closely related Bacillus species, including B. amyloliquefaciens, B. pumilus and B. velezensis (which are also used to produce microbial fermentation products), as well as B. atrophaeus, B. mojavensis, B. sonorensis, B. tequilensis and B. vallismortis. These Bacillus species present, at minimum, 99% similarity at the 16S rRNA sequence level as well as very few or no phenotypic and biochemical distinctions [28,32,33]. To date, all of the GMM contaminations that have been observed on the food and feed market have concerned bacterial species belonging to the B. subtilis group, being a vitamin B2-producing GM B. subtilis strain, a protease-producing GM B. velezensis strain, a alpha-amylase-producing GM B. amyloliquefaciens strain and a protease-producing GM B. amyloliquefaciens strain [2,3,8,9,10,11,13,38]. The presence of such bacterial species represents, thus, a strong indicator of the potential GMM contaminations in a given sample. Therefore, a real-time PCR method targeting bacterial species from the B. subtilis group was developed and designed in this study to be compatible with the first-line screening condition of the GMM detection strategy, allowing the strengthening of the latter.
To this end, this taxon-specific real-time PCR method, named BSG, was designed in this study on a part of the 16S-23S region (Table 1 and Table S1). This sequence of interest was previously identified [28,30] as being specific to the B. subtilis group, including the bacterial species that are commonly used to produce microbial fermentation products (B. subtilis, B. licheniformis, B. amyloliquefaciens, B. pumilus and B. velezensis) [4,5,6,7,25]. The 16S-23S region belongs to the bacterial ribosomal RNA operon, playing a key role in protein synthesis. The number of copies per genome of this ribosomal RNA operon varies between and within bacterial species, ranging from 6 to 15 for Bacillus sp. The developed BSG method, generating PCR amplicons with a size range from 137 to 165 bp, is the first real-time PCR method that was designed to specifically target the B. subtilis group in order to control the GMM contaminations in microbial fermentation products [28,30,32,33,39,40] (Table 1 and Table S1).

3.2. Specificity Assessment of the BSG Method

The specificity of the developed BSG method was first confirmed in silico using SCREENED on a dataset that was composed of animal (75548 items), archaea (54464 items), bacteria (11507253 items), fungi (86250 items), plant (46015 items), protist (89957 items) and virus (10108 items) sequences that were extracted from the NCBI RefSeq Nucleotide database, allowing the present study to theoretically determine the generation of a PCR amplification (Tables S1 and S2) [34,35]. On this basis, a PCR amplification was only predicted for 167 bacterial sequences from the Bacillus genus. Among these 167 sequences, 15 belonged to unclassified Bacillus species and 152 belonged to the B. subtilis group, including B. amyloliquefaciens (14 sequences), B. licheniformis (11 sequences), B. mojavensis group (4 sequences), B. pumilus group (29 sequences) B. subtilis (42 sequences), B. vallismortis (1 sequence) and B. velezensis (51 sequences). No PCR amplification was predicted for non-targeted sequences, including Bacillus species not belonging to the B. subtilis group (for example, species of the B. brevis, B. cereus, B. circulans and B. megaterium groups) (Tables S1 and S2).
Second, the specificity of the BSG method was experimentally assessed. As positive controls, 26 bacterial strains from 5 Bacillus species belonging to the B. subtilis group (B. amyloliquefaciens, B. licheniformis, B. pumilus, B. subtilis and B. velezensis) were used. Among these 26 bacterial strains, 2 GMM strains were included, namely a vitamin B2-producing GM B. subtilis strain (RASFF2014.1249) and a protease-producing GM B. velezensis strain (RASFF2019.3332). As negative controls, 29 bacterial species from 17 non-Bacillus genera (Arthrobacter, Cellulosimicrobium, Corynebacterium, Enterococcus, Escherichia, Geobacillus, Klebsiella, Lactobacillus, Lactococcus, Leuconostoc, Microbacterium, Paenibacillus, Protaminobacter, Pseudomonas, Pullulanibacillus, Streptomyces and Streptoverticillium), and 9 Bacillus species not belonging to the B. subtilis group (B. brevis, B. cereus, B. circulans, B. coagulans, B. firmus, B. flexus, B. lentus, B. megaterium and B. smithii) were tested. In addition to the bacterial strains, 37 fungal species as well as plant and animal samples were used as negative controls (Table 2). As expected, no amplification was observed for all of the negative controls while all of the positive controls presented a positive signal. Although all of the positive controls were tested at the same DNA concentration, a variation in their Cq values was observed. This could be explained by the natural copy number variation of the 16S–23S region that was targeted by the developed BSG method [28,32,33].
Based on these results, the developed BSG method was assessed as specific because, firstly, a positive signal was only observed in the samples that were presenting the targeted sequences and, secondly, no false positive and negative signals were observed. This method currently represents the first taxon-specific real-time PCR method targeting GMM contaminations in microbial fermentation products for which a large spectrum of targeted and non-targeted sequences that are related to microorganisms that are used to produce fermentation products were investigated.

3.3. Sensitivity Assessment of the BSG Method

In order to assess the sensitivity of the developed BSG method, DNA from a control plasmid that was artificially synthetized to carry one copy of the targeted sequence from B. subtilis was used to prepare the serial dilution points, from 100 to 0.1 estimated target copy number (Table 3 and Table S3).
A positive signal was observed as low as 20 estimated target copies for all 12 of the replicates. Moreover, a positive signal was detected as low as 1 estimated target copy. Based on these results, the LOD95% was subsequently determined at 22 estimated target copies, indicating that the developed BSG method is sensitive. This taxon-specific method represents the first real-time PCR method that is designed to specifically target the B. subtilis group with performance complying with the Minimum Performance Requirements for Analytical Methods of GMO Testing of the European Network of GMO Laboratories, being used as a standard in GMO enforcement laboratories, allowing to support enforcement laboratories for the control of GMM contaminations in microbial fermentation products [24,28,30,39,40].

3.4. Applicability Assessment of the BSG Method

The applicability of the developed BSG method was tested using several commercial microbial fermentation products that are intended for use in various sectors, such as livestock farming, baking, distillery, brewing, diary processing, protein processing or fruit processing (Table 4).
Among the 25 investigated samples, 18 of them were previously notified for a contamination with the vitamin B2-producting GM B. subtilis strain (samples n°1–2), the protease-producing GM B. velezensis strain (samples n°3–16), the alpha-amylase-producing GM B. amyloliquefaciens strain (samples n°3–17) or the protease-producing GM B. amyloliquefaciens strain (sample n°18). As expected, all of these samples presented a positive signal for the BSG method, highlighting the possibility of using this taxon-specific method as an indicator of potential GMM contaminations (Table 4).
Regarding the 7 remaining samples (n°19–25), no GMM contamination was previously reported based on the negative signals for the second-line methods that were targeting the currently known GM strains (Table 4). Among these 7 samples, a contamination with bacterial DNA was previously observed for the samples n°19–22 (a positive signal for the 16S-rRNA marker) and discarded for the samples n°23–25 (a negative signal for the 16S-rRNA marker) (Table 4). Using the BSG method, a positive signal was detected for the sample n°19 while the samples n°20–25 presented a negative signal (Table 4). On this basis, the previously reported bacterial DNA contamination was associated to bacterial species that are related to the B. subtilis group, as in the case of the sample n°19, or not, as in the case of the samples n°20–22. In addition, given that no bacterial DNA contamination was previously observed in the samples n°23–25, the negative signal for the BSG method was expected. According to all of these results, the applicability of the developed BSG method was confirmed.

3.5. Illustration of the Reinforcement of the First-Line Screening Analysis Step Using the BSG Method

The BSG method was developed in order to strengthen the GMM detection strategy by completing the set of first-line screening methods targeting the key sequences that are frequently found in GM bacteria. To illustrate this reinforcement, the presence or absence of PCR amplification that was observed for the full set of first-line screening real-time PCR methods (BSG, cat, tet-L, aadD, pUB110) were indicated for few commercial microbial fermentation products (samples n°2–4, 6, 19-20, 22, 25) (Table 5).
For the samples n°2–4 and 6, positive signals for the cat, tet-L, aadD and/or pUB110 methods as well as for the BSG method were observed, indicating potential contaminations with GM bacteria belonging to B. subtilis group. This hypothesis was confirmed by the previous detection of the vitamin B2-producing GM B. subtilis strain (sample n°2), the protease-producing GM B. velezensis strain (samples n°3–4, 6) and the alpha-amylase-producing GM B. amyloliquefaciens (samples n°3–4, 6) (Table 5). For the sample n°19, a negative signal was obtained for all of the methods that were targeting key genetic elements that are found in GM bacteria while the BSG method presented a positive signal, suggesting a contamination with bacteria from the B. subtilis group (Table 5). Regarding the sample n°20, the positive signal for the aadD method associated to the negative signal for the BSG method suggests a potential contamination that is not related to bacteria belonging to the B. subtilis group, including bacteria naturally carrying the detected AMR gene (e.g., Staphylococcus sp.) or a new unknown GMM (Table 5). Finally, for the samples n°22 and 25, only negative signals were observed for all of the screening markers, discarding contamination with bacteria from B. subtilis group as well as bacteria naturally carrying the targeted AMR genes and shuttle vectors (e.g., Enterococcus sp., Staphylococcus sp. or Streptococcus sp.) (Table 5) [5,6,7,8,9]. Based on all of these results, the added value of the developed BSG method to strengthen the first-line screening analysis step was thus highlighted, allowing the indication of potential contaminations with bacteria from the B. subtilis group, GM or not.
The BSG method was developed in order to be used as an indicator of the potential presence of GMM contaminations. Similar to its application to GM plants, this taxon-specific BSG method can also be applied to specifically target GM Bacillus strains, supporting the identification of such GMM. However, as the targeted 16S-23S region is naturally present in several copies per bacterial genome, ranging from 6 to 15 copies for Bacillus species, another target will need to be selected in case a taxon-specific method is required in the future for the quantification of GMM [24,28,30,39,40]. In addition, given the high copy number of the targeted 16S-23S region that is naturally present in bacteria, potential issues for the interpretation of the results may be encountered in the case of GMM contaminations at trace level (e.g., a late positive signal for the BSG method and a negative signal for the method specifically targeting a GM Bacillus strain). It should also be mentioned that the sequences that are targeted by the other screening methods (cat, tet-L, aadD and pUB110) may also be present in a GMM at a high copy number. Indeed, these sequences were previously found as being carried by plasmids or introduced multiple times in the host genome [2,3,4,5,6,7,8,9,10,11,12,13,38]. Consequently, in case of late signals from screening methods, the need for further investigations will depend on the nature of the contaminated products as well as the final decision of the competent authorities.

4. Conclusions

In order to control GMO, including GMM, in the food and feed chain, an efficient screening tool covering a large spectrum of key targets is essential to allow the identification of samples with potential GMO contaminations. To this end, a combination of taxon-specific and genetic element-specific methods are needed.
Regarding the control of GM bacteria, only screening methods that were targeting key genetic elements that are commonly found in GMM were only available and no taxon-specific method, designed to be compatible with the technical requirements of the GMM detection strategy as well as harboring performance in line with the Minimum Performance Requirements for Analytical Methods of GMO Testing of the European Network of GMO Laboratories used as a standard in GMO enforcement laboratories, was available to target GMM contaminations.
In order to meet this need, the BSG method was therefore developed and validated in this sense in the present study. This taxon-specific real-time PCR method was designed to target bacterial species belonging to the B. subtilis group, covering most of the GM bacterial species that are used by the food industry to produce microbial fermentation products [3,6,8,9,10,11,13,24,31]. The performance of the BSG method, successfully assessed as specific and sensitive, complies with the requirements of the GMO enforcement laboratories. In addition, the BSG method also represents an interesting tool for screening viable B. subtilis group strains isolable from the food–feed matrix.
By completing the set of screening methods of the first-line screening analysis step, the BSG method strengthens the GMM detection strategy that is used to control the GMM contaminations in the food and feed chain. Indeed, the sequences that are targeted by the cat, tet-L, aadD and pUB110 methods are usually not naturally carried by the bacterial species from the B. subtilis group [5,6,7,8,9]. Therefore, when combined with a positive signal for at least one of the cat, tet-L, aadD and pUB110 methods, the detection of a positive signal for the BSG method is considered as a strong indicator of potential GM bacterial contaminations, allowing the identification of suspicious samples for further analysis.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/fermentation8020078/s1, Table S1: In silico analysis for the specificity of the BSG method using SCREENED, Table S2: Misclassification of NZ_CLNG01000048.1, Table S3: Calculation of LOD95% based on the POD curve for the developed real-time PCR BSG method.

Author Contributions

Conceptualization, M.-A.F. and N.H.C.R.; methodology, M.-A.F. and N.H.C.R.; formal analysis, M.-A.F., A.G., N.P. and N.H.C.R.; writing—original draft preparation, M.-A.F.; writing—review and editing, M.-A.F., A.G., N.P. and N.H.C.R. All authors have read and agreed to the published version of the manuscript.

Funding

The research that yielded these results was both funded by the Belgian Federal Public Service of Health, Food Chain Safety and Environment through the contract [RT 17/5 SPECENZYM] and the Transversal activities in Applied Genomics (TAG) Service from Sciensano.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The research that yielded these results was both funded by the Belgian Federal Public Service of Health, Food Chain Safety and Environment through the contract [RT 17/5 SPECENZYM] and the Transversal activities in Applied Genomics (TAG) Service from Sciensano. The Sanger sequencing was performed by TAG. The authors would like also to thank Kevin Vanneste for his support in the bioinformatics analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. The European Parliament and of the Council. Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC. Off. J. Eur. Union 2003, L268, 24–28. [Google Scholar]
  2. Barbau-Piednoir, E.; De Keersmaecker, S.C.J.; Wuyts, V.; Gau, C.; Pirovano, W.; Costessi, A.; Philipp, P.; Roosens, N.H.C. Genome sequence of the EU-unauthorized genetically modified Bacillus subtilis strain 2014–3557 overproducing riboflavin, isolated from an imported lot of Vitamin B2 80% feed additive. Genome Announc. 2015, 3, e00214-5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Barbau-Piednoir, E.; De Keersmaecker, S.C.J.; Delvoye, M.; Gau, C.; Philipp, P.; Roosens, N.H.C. Use of next generation sequencing data to develop a qPCR method for specific detection of EU-unauthorized genetically modified Bacillus subtilis overproducing riboflavin. BMC Biotechnol. 2015, 15, 103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Deckers, M.; De Loose, M.; Papazova, N.; Deforce, D.; Fraiture, M.A.; Roosens, N.H.C. First Monitoring for Unauthorized Genetically Modified Bacteria in Food Enzymes from the Food Market. Food Control 2021, 135, 108665. [Google Scholar] [CrossRef]
  5. Fraiture, M.A.; Deckers, M.; Papazova, N.; Roosens, N.H.C. Detection strategy targeting a chloramphenicol resistance gene from genetically modified bacteria in food and feed products. Food Control 2020, 18, 106873. [Google Scholar] [CrossRef]
  6. Fraiture, M.A.; Deckers, M.; Papazova, N.; Roosens, N.H.C. Are antimicrobial resistance genes key targets to detect genetically modified microorganisms in fermentation products? Int. J. Food Microbiol. 2020, 331, 108749. [Google Scholar] [CrossRef] [PubMed]
  7. Fraiture, M.A.; Deckers, M.; Papazova, N.; Roosens, N.H.C. Strategy to detect genetically modified bacteria carrying tetracycline resistance gene in fermentation products. Food Anal. Methods 2020, 13, 1929–1937. [Google Scholar] [CrossRef]
  8. Fraiture, M.A.; Bogaerts, B.; Winand, R.; Deckers, M.; Papazova, N.; Vanneste, K.; De Keersmaecker, S.C.J.; Roosens, N.H.C. Next-generation sequencing: A key tool to identify unauthorized genetically modified microorganisms in food enzyme preparations. Sci. Rep. 2020, 10, 7094. [Google Scholar] [CrossRef]
  9. Fraiture, M.A.; Papazova, N.; Roosens, N.H.C. DNA walking strategy to identify unauthorized genetically modified bacteria in microbial fermentation products. Int. J. Food Microbiol. 2021, 337, 108913. [Google Scholar] [CrossRef]
  10. Fraiture, M.A.; Marchesi, U.; Verginelli, D.; Papazova, N.; Roosens, N.H.C. Development of a real-time PCR method targeting an unauthorized genetically modified microorganism producing alpha-amylase. Food Anal. Methods 2021, 14, 2211–2220. [Google Scholar] [CrossRef]
  11. Fraiture, M.A.; Gobbo, A.; Marchesi, U.; Verginelli, D.; Papazova, N.; Roosens, N.H.C. Development of a Real-Time PCR Marker Targeting a New Unauthorized Genetically Modified Microorganism Producing Protease Identified by DNA Walking. Int. J. Food Microbiol. 2021, 354, 109330. [Google Scholar] [CrossRef] [PubMed]
  12. Fraiture, M.A.; Joly, L.; Vandermassen, E.; Delvoye, M.; Van Geel, D.; Michelet, J.Y.; Van Hoeck, E.; De Jaeger, N.; Papazova, N.; Roosens, N.H.C. Retrospective Survey of Unauthorized Genetically Modified Bacteria Harbouring Antimicrobial Resistance Genes in Feed Additive Vitamin B2 Commercialized in Belgium: Challenges and Solutions. Food Control 2021, 119, 107476. [Google Scholar] [CrossRef]
  13. Paracchini, V.; Petrillo, M.; Reiting, R.; Angers-Loustau, A.; Wahler, D.; Stolz, A.; Schönig, B.; Matthies, A.; Bendiek, J.; Meinel, D.M.; et al. Molecular characterization of an unauthorized genetically modified Bacillus subtilis production strain identified in a vitamin B2 feed additive. Food Chem. 2017, 230, 681–689. [Google Scholar] [CrossRef] [PubMed]
  14. RASFF Portal. Available online: https://webgate.ec.europa.eu/rasff-window/portal/?event=SearchForm&cleanSearch=1 (accessed on 13 January 2022).
  15. Deckers, M.; Deforce, D.; Fraiture, M.A.; Roosens, N.H.C. Genetically modified micro-organisms for industrial food enzyme. Foods 2020, 9, 326. [Google Scholar] [CrossRef] [Green Version]
  16. Florez-Cuadrado, D.; Moreno, M.A.; Ugarte-Ruíz, M.; Domínguez, L. Antimicrobial Resistance in the Food Chain in the European Union. Adv. Food Nutr. Res. 2018, 86, 115–136. [Google Scholar]
  17. Nadeem, S.F.; Gohar, U.F.; Tahir, S.F.; Mukhtar, H.; Pornpukdeewattana, S.; Nukthamna, P.; Moula Ali, A.M.; Bavisetty, S.C.B.; Massa, S. Antimicrobial resistance: More than 70 years of war between humans and bacteria. Crit. Rev. Microbiol. 2020, 46, 578–599. [Google Scholar] [CrossRef]
  18. Tóth, A.G.; Csabai, I.; Krikó, E.; Tőzsér, D.; Maróti, G.; Patai, Á.V.; Makrai, L.; Szita, G.; Solymosi, N. Antimicrobial resistance genes in raw milk for human consumption. Sci. Rep. 2020, 10, 7464. [Google Scholar] [CrossRef]
  19. von Wintersdorff, C.J.H.; Penders, J.; van Niekerk, J.M.; Mills, N.D.; Majumder, S.; van Alphen, L.B.; Savelkoul, P.H.M.; Wolffs, P.F.G. Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer. Front. Microbiol. 2016, 7, 173. [Google Scholar] [CrossRef] [Green Version]
  20. Von Wrighta, A.; Bruce, A. Genetically modified microorganisms and their potential effects on human health and nutrition. Trends Food Sci. Technol. 2003, 14, 264–276. [Google Scholar] [CrossRef]
  21. Fraiture, M.A.; Herman, P.; Taverniers, I.; De Loose, M.; Deforce, D.; Roosens, N.H.C. Current and New Approaches in GMO Detection: Challenges and Solutions. BioMed Res. Int. 2015, 2015, 392872. [Google Scholar] [CrossRef] [Green Version]
  22. Broeders, S.R.M.; De Keersmaecker, S.C.J.; Roosens, N.H.C. How to Deal with the Upcoming Challenges in GMO Detection in Food and Feed. BioMed Res. Int. 2012, 2012, 402418. [Google Scholar] [CrossRef] [PubMed]
  23. Bonfini, L.; Van den Bulcke, M.H.; Mazzara, M.; Ben, E.; Patak, A. GMOMETHODS: The European Union database of reference methods for GMO analysis. J. AOAC Int. 2012, 95, 1713–1719. [Google Scholar] [CrossRef] [PubMed]
  24. ENGL. Definition of Minimum Performance Requirements for Analytical Methods for GMO Testing. 2015. Available online: http://gmo-crl.jrc.ec.europa.eu/doc/MPR%20Report%20Application%2020_10_2015.pdf (accessed on 13 January 2022).
  25. Deckers, M.; Vanneste, K.; Winand, R.; De Keersmaecker, S.C.J.; Denayer, S.; Heyndrickx, M.; Deforce, D.; Fraiture, M.A.; Roosens, N.H.C. Strategy for the Identification of Micro-Organisms Producing Food and Feed Products: Bacteria Producing Food Enzymes as Study Case. Food Chem. 2020, 305, 125431. [Google Scholar] [CrossRef] [Green Version]
  26. Kleinschmidt, K.; Wilkens, E.; Glaeser, S.P.; Kaempfer, P.; Staerk, A.; Roesti, D. Development of a qualitative real-time PCR for microbiological quality control testing in mammalian cell culture production. J. Appl. Microbiol. 2017, 122, 997–1008. [Google Scholar] [CrossRef] [PubMed]
  27. Cangiano, G.; Sirec, T.; Panarella, C.; Isticato, R.; Baccigalupi, L.; De Felice, M.; Ricca, E. The sps Gene Products Affect the Germination, Hydrophobicity, and Protein Adsorption of Bacillus subtilis Spores. Appl. Environ. Microbiol. 2014, 80, 7293–7302. [Google Scholar] [CrossRef] [Green Version]
  28. Solichová, K.; Němečková, I.; Šviráková, E.; Horáčková, Š. Novel identification methods including a species-specific PCR for hazardous Bacillus species. Acta Aliment. 2019, 48, 4. [Google Scholar] [CrossRef] [Green Version]
  29. Fernández-No, I.C.; Guarddon, M.; Böhme, K.; Cepeda, A.; Calo-Mata, P.; Barros-Velázquez, J. Detection and quantification of spoilage and pathogenic Bacillus cereus, Bacillus subtilis and Bacillus licheniformis by real-time PCR. Food Microbiol. 2011, 28, 605–610. [Google Scholar] [CrossRef]
  30. Kaewklom, S.; Chueakhalm, W.; Suthirawut, S.; Aunpad, R. Development of a Novel PCR Primer to Differentiate and Identify Bacillus subtilis and Closely Related Species Isolated from Thai Fermented Foods. Food Biotechnol. 2014, 28, 354–368. [Google Scholar] [CrossRef]
  31. EFSA Panel on Biological Hazards. Scientific Opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA. EFSA J. 2017, 15, 4664. [Google Scholar]
  32. Valdivia-Anistro, J.A.; Eguiarte-Fruns, L.E.; Delgado-Sapién, G.; Márquez-Zacarías, P.; Gasca-Pineda, J.; Learned, J.; Elser, J.J.; Olmedo-Alvarez Gand Souza, V. Variability of rRNA Operon Copy Number and Growth Rate Dynamics of Bacillus Isolated from an Extremely Oligotrophic Aquatic Ecosystem. Front. Microbiol. 2016, 6, 1486. [Google Scholar] [CrossRef] [Green Version]
  33. Sicuia, O.A.; Florica, C.; Cornea, C.P. Biodiversity of Bacillus subtilis group and beneficial traits of Bacillus species useful in plant protection. Rom. Biotechnol. Lett. 2015, 20, 5. [Google Scholar]
  34. Vanneste, K.; Garlant, L.; Broeders, S.; Van Gucht, S.; Roosens, N.H. Application of whole genome data for in silico evaluation of primers and probes routinely employed for the detection of viral species by RT-qPCR using dengue virus as a case study. BMC Bioinform. 2018, 19, 1–18. [Google Scholar] [CrossRef] [PubMed]
  35. Gand, M.; Vanneste, K.; Thomas, I.; Van Gucht, S.; Capron, A.; Herman, P.; Roosens, N.H.C.; De Keersmaecker, S.C.J. Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection. Int. J. Mol. Sci. 2020, 21, 5585. [Google Scholar] [CrossRef] [PubMed]
  36. Uhlig, S.; Frost, K.; Colson, B.; Simon, K.; Made, D.; Reiting, R.; Gowig, P.; Grohmann, L. Validation of qualitative PCR methods on the basis of mathematical-statistical modelling of the probability of detection. Accred. Qual. Assur. 2015, 20, 75–83. [Google Scholar] [CrossRef]
  37. Grohmann, L.; Broll, H.; Dagand, E.; Hildebrandt, S.; Hübert, P.; Kiesecker, H.; Lieske, K.; Mäde, D.; Mankertz, J.; Reiting, R.; et al. Guidelines for the Validation of Qualitative Real-Time PCR Methods by Means of a Collaborative Study; Technical Report BVL1; Federal Office of Consumer Protection and Food Safety: Berlin, Germany, 2016. [Google Scholar]
  38. Berbers, B.; Saltykova, A.; Garcia-Graells, C.; Philipp, P.; Arella, F.; Marchal, K.; Winand, R.; Vanneste, K.; Roosens, N.H.; De Keersmaecker, S.C.J. Combining short and long read sequencing to characterize antimicrobial resistance genes on 2 plasmids applied to an unauthorized genetically modified Bacillus. Sci. Rep. 2020, 10, 4310. [Google Scholar] [CrossRef]
  39. Wattiau, P.; Renard, M.E.; Ledent, P.; Debois, V.; Blackman, G.; Agathos, S.N. A PCR test to identify bacillus subtilis and closely related species and its application to the monitoring of wastewater biotreatment. Appl. Microbiol. Biotechnol. 2001, 56, 816–819. [Google Scholar] [CrossRef]
  40. Borshchevskaya, L.N.; Kalinina, A.N.; Sineokii, S.P. Design of a PCR test based on the gyrA gene sequence for the identification of closely related species of the Bacillus subtilis group. Appl. Biochem. Microbiol. 2013, 49, 646–655. [Google Scholar] [CrossRef]
Table 1. Oligonucleotides of the real-time PCR BSG method targeting bacterial species belonging to B. subtilis group that are used to produce microbial fermentation products. On the targeted sequences, the location of the used oligonucleotides is indicated in bold.
Table 1. Oligonucleotides of the real-time PCR BSG method targeting bacterial species belonging to B. subtilis group that are used to produce microbial fermentation products. On the targeted sequences, the location of the used oligonucleotides is indicated in bold.
Targeted Sequences
B_pumilus_CP054310.1 CGTGCGCCCTTTCTAACTTAACCATTTCTTACTTTAGAAAGAATCACTATGTGTGATGAA
B_licheniformis_CP045814.1CGTGCGCCCTTTCTAACTTAACCG---------TTAAAAAGAATCACTACAGA----AAA
B_amyloliquefaciens_CP054479.1CGTGCGCCCTTTCTAACTTAACCG---------TTAAAAAGAATCACTACGTG----ATA
B_velezensis_CP055160.1CGTGCGCCCTTTCTAACTTAACCG---------TTAAAAAGAATCACTACGTG----ATA
B_subtilis_CP054177.1CGTGCGCCCTTTCTAACTTAACCG---------TTAAAAAGAATCACTATGTG----ATA
***********************            *** ************            *
B_pumilus_CP054310.1CTTTGCATTGC--ATTCAATGTGAATGTATTACTTATTGTTATCTAGTTTTCAAAGAACA
B_licheniformis_CP045814.1TTCT---------------TGTGAATGTCT--ACTTTCGTTATCTAGTTTTCAAAGAACA
B_amyloliquefaciens_CP054479.1TCTTGCATTACTAATTGAATGTGAATTA-----CTTCTGTTATCTAGTTTTCAAAGAACA
B_velezensis_CP055160.1TCTTGCATTACTAATTGAATGTGAATTA-----CTTCTGTTATCTAGTTTTCAAAGAACA
B_subtilis_CP054177.1TCTTGTGTTACTAATTGAATGTG-ATGT-----CTACTGTTATCTAGTTTTCAAAGAACA
    *                  **** **        *   **********************
B_pumilus_CP054310.1CGTTGGTGGAGCCTAGCGGGATCGAACCGCTGACCTCCTGCGTGCAA
B_licheniformis_CP045814.1CGTTGGTGGAGCCTAGCGGGATCGAACCGCTGACCTCCTGCGTGCAA
B_amyloliquefaciens_CP054479.1CGTTGGTGGAGCCTAGCGGGATCGAACCGCTGACCTCCTGCGTGCAA
B_velezensis_CP055160.1CGTTGGTGGAGCCTAGCGGGATCGAACCGCTGACCTCCTGCGTGCAA
B_subtilis_CP054177.1CGTTGGTGGAGCCTAGCGGGATCGAACCGCTGACCTCCTGCGTGCAA
***********************************************
OligonucleotidesAnnealing temperatureExpected amplicon sizes
NamesSequences
BSG-FCGTGCGCCCTTTCTAAC64 °C137–165 bp
BSG-PFAM-CAAAGAACACGTTGGTGGAGCCTAGC-TAMRA
BSG-RTTGCACGCAGGAGGT
Table 2. Specificity assessment of the developed real-time PCR BSG method. The presence and absence of amplification are symbolized by “+” and “−“, respectively. For each result, the experiment was carried out in triplicate on 10 ng of each sample. The means of the observed Cq are indicated in brackets.
Table 2. Specificity assessment of the developed real-time PCR BSG method. The presence and absence of amplification are symbolized by “+” and “−“, respectively. For each result, the experiment was carried out in triplicate on 10 ng of each sample. The means of the observed Cq are indicated in brackets.
KingdomGenusSpeciesStrain NumberBSG Method
FungiAspergillusacidusIHEM 26285-
AspergillusaculeatusIHEM 05796-
AspergillusfijiensisIHEM 22812-
AspergillusmelleusIHEM 25956-
AspergillusnigerIHEM 25485-
AspergillusoryzaeIHEM 25836-
CandidacylindraceaMUCL 041387-
CandidarugosaIHEM 01894-
ChaetomiumgracileMUCL 053569-
CryphonectriaparasiticaMUCL 007956-
DisporotrichumdimorphosporumMUCL 019341-
FusariumvenenatumMUCL 055417-
HansenulapolymorphaMUCL 027761-
HumicolainsolensMUCL 015010-
KluyveromyceslactisIHEM 02051-
LeptographiumprocerumMUCL 008094-
MucorjavanicusIHEM 05212-
PenicilliumcamembertiIHEM 06648-
PenicilliumchrysogenumIHEM 03414-
PenicilliumcitrinumIHEM 26159-
PenicilliumdecumbensIHEM 05935-
PenicilliumfuniculosumMUCL 014091-
PenicilliummulticolourCBS 501.73-
PenicilliumroquefortiIHEM 20176-
PichiapastorisMUCL 027793-
RhizomucormieheiIHEM 26897-
RhizopusniveusATCC 200757-
RhizopusoryzaeIHEM 26078-
SaccharomycescerevisiaeIHEM 25104-
SporobolomycessingularisMUCL 027849-
Talaromycescellulolyticus/pinophilusIHEM 16004-
TalaromycesemersoniiDSM 2432-
TrameteshirsutaMUCL 030869-
TrichodermacitrinovirideIHEM 25858-
TrichodermalongibrachiatumIHEM 00935-
TrichodermareeseiIHEM 05651-
TrichodermavirideIHEM 04146-
BacteriaArthrobacterramosusLMG 17309-
BacillusamyloliquefaciensLMG 98140+ (Cq: 16.6)
BacillusamyloliquefaciensLMG12325+ (Cq: 18.6)
BacillusamyloliquefaciensLMG12329+ (Cq: 16.7)
BacillusamyloliquefaciensLMG12331+ (Cq: 19.9)
BacillusamyloliquefaciensLMG12326+ (Cq: 19.8)
BacillusamyloliquefaciensLMG12327+ (Cq: 19.1)
BacillusbrevisLMG 7123-
BacilluscereusATCC 14579-
BacilluscirculansLMG 6926T-
BacilluscoagulansLMG 6326-
BacillusfirmusLMG 7125-
BacillusflexusLMG 11155 -
BacilluslentusTIAC 101-
BacilluslicheniformisLMG 6933T+ (Cq: 17.9)
BacilluslicheniformisLMG6934+ (Cq: 19.0)
BacilluslicheniformisLMG7558+ (Cq: 18.2)
BacilluslicheniformisLMG7634+ (Cq: 17.9)
BacilluslicheniformisLMG7631+ (Cq: 18.3)
BacillusmegateriumLMG 7127-
BacilluspumilusDSMZ 1794+ (Cq: 16.5)
BacillussmithiiLMG 6327-
BacillussubtilisLMG 7135 T+ (Cq: 19.0)
BacillussubtilisW04-510+ (Cq: 22.4)
BacillussubtilisE07-505+ (Cq: 20.6)
BacillussubtilisS10005+ (Cq: 21.0)
BacillussubtilisSUB033+ (Cq: 21.3)
BacillussubtilisBNB54+ (Cq: 29.2)
BacillussubtilisGMM RASFF2014.1249 + (Cq: 19.7)
BacillusvelezensisLMG 12384+ (Cq: 20.0)
BacillusvelezensisLMG 17599+ (Cq: 16.4)
BacillusvelezensisLMG 22478+ (Cq: 16.1)
BacillusvelezensisLMG 23203+ (Cq: 16.4)
BacillusvelezensisLMG 26770+ (Cq: 16.3)
BacillusvelezensisLMG 27586+ (Cq: 16.4)
BacillusvelezensisGMM RASFF2019.3332+ (Cq: 17.8)
CellulosimicrobiumcellulansLMG 16121-
CorynebacteriumglutamicumLMG 3652-
EnterococcusfaeciumLMG 9430-
EscherichiacoliLMG2092T-
GeobacilluscaldoproteolyticusDSM 15730-
GeobacilluspallidusLMG 11159T-
GeobacillusstearothermophilusLMG 6939T-
KlebsiellapneumoniaLMG 3113T-
LactobacilluscaseiLMG 6904-
LactobacillusfermentumLMG 6902 -
LactobacillusplantarumLMG 9208-
LactobacillusrhamnosusLMG 18030-
LactococcuslactisLMG 6890T-
LeuconostoccitreumLMG 9824 -
MicrobacteriumimperialeLMG 20190-
PaenibacillusalginolyticusLMG 18723 -
PaenibacillusmaceransLMG 6324-
ProtaminobacterrubrumCBS 574.77-
PseudomonasamyloderamosaATCC-21262-
PseudomonasfluorescensLMG1794T-
PullulanibacillusnaganoensisLMG 12887 -
StreptomycesaureofaciensLMG 5968-
StreptomycesmobaraensisDSM 40847-
StreptomycesmurinusLMG 10475 -
StreptomycesnetropsisLMG 5977 -
StreptomycesrubiginosusLMG20268-
StreptomycesviolaceoruberLMG 7183-
StreptoverticilliummobaraenseCBS 199.75-
PlantaeZeamays/-
AnimaliaHomosapiens/-
Table 3. Sensitivity assessment of the developed real-time PCR BSG method using a control plasmid carrying one copy of the targeted sequence from B. subtilis. The presence and absence of amplification are symbolized by “+” and “−“, respectively. For each target copy number, 12 replicates were tested. The number of positive replicates out of the 12 replicates tested is indicated and the means of the observed Cq are indicated in brackets.
Table 3. Sensitivity assessment of the developed real-time PCR BSG method using a control plasmid carrying one copy of the targeted sequence from B. subtilis. The presence and absence of amplification are symbolized by “+” and “−“, respectively. For each target copy number, 12 replicates were tested. The number of positive replicates out of the 12 replicates tested is indicated and the means of the observed Cq are indicated in brackets.
Estimated Target Copy Number
1002010510.10
BSG method+++++
(12/12)(12/12)(8/12)(6/12)(1/12)(0/12)(0/12)
(Cq: 38.2)(Cq: 41.1)(Cq: 42.0)(Cq: 42.6)(Cq: 43.5)
Table 4. Applicability assessment of the developed real-time PCR BSG method using commercialized microbial fermentation products. The BSG method was applied on 25 samples. For each sample, labelled information related to enzyme/additive microbial production sources, forms and application fields is indicated. Each sample was tested at a concentration of 10 ng in duplicate. The presence or absence of PCR amplification is symbolized by “+” or “−“, respectively. The means of the observed Cq are indicated in brackets. Available information related to previously reported contaminations (GMM, Bacterial DNA) is also indicated for each sample. * Successful isolation of the GMM strain previously reported.
Table 4. Applicability assessment of the developed real-time PCR BSG method using commercialized microbial fermentation products. The BSG method was applied on 25 samples. For each sample, labelled information related to enzyme/additive microbial production sources, forms and application fields is indicated. Each sample was tested at a concentration of 10 ng in duplicate. The presence or absence of PCR amplification is symbolized by “+” or “−“, respectively. The means of the observed Cq are indicated in brackets. Available information related to previously reported contaminations (GMM, Bacterial DNA) is also indicated for each sample. * Successful isolation of the GMM strain previously reported.
SamplesSourcesFormsApplicationBSG MethodAvailable InformationReferences
1Feed additive
vitamin B2
UnknownSolidLivestock farming+
(Cq: 23.1)
GM B. subtilis producing vitamin B2 * RASFF2014.1249, [3,14]
2Feed additive
vitamin B2
UnknownSolidLivestock farming+
(Cq: 38.6)
GM B. subtilis producing vitamin B2RASFF2018.2755, [9,12,14]
3Food enzyme
neutral protease
Bacillus sp. SolidBaking, distillery, brewing+
(Cq: 19.5)
GM B. velezensis producing protease *
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,8,14]
4Food enzyme
alpha-amylase
Bacillus sp. SolidDistillery, brewing+
(Cq: 20.1)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,10,14]
5Food enzyme
alpha-amylase
Bacillus sp. LiquidDistillery, brewing+
(Cq: 34.4)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2576, [4,10,14]
6Food enzyme
alpha-amylase, protease, cellulose, xylanase, beta-glucanase
Aspergillus sp., Bacillus sp., Trichoderma sp. SolidDistillery, brewing+
(Cq: 20.6)
GM B. velezensis producing protease *
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,10,14]
7Food enzyme
alpha-amylase
Aspergillus sp. SolidDistillery, brewing, baking+
(Cq: 40.3)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,10,14]
8Food enzyme
alpha-amylase
UnknownLiquidUnknown+
(Cq: 27.9)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,10,14]
9Food enzyme
alpha-amylase
UnknownLiquidDistillery+
(Cq: 42.4)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2870, [4,10,14]
10Food enzyme
alpha-amylase
BacteriaLiquidDistillery, brewing+
(Cq: 19.8)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2846, [14]
11Food enzyme
alpha-amylase
BacteriaSolidDistillery, brewing+
(Cq: 22.6)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2579, [14]
12Food enzyme
alpha-amylase
UnknownSolidDistillery+
(Cq: 19.4)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2577, [14]
13Food enzyme
alpha-amylase
UnknownSolidDistillery+
(Cq: 19.5)
GM B. velezensis producing protease *
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2582, [14]
14Food enzyme
alpha-amylase
UnknownSolidDistillery, brewing+
(Cq: 31.2)
GM B. velezensis producing protease*
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2582, [14]
15Food enzyme
alpha-amylase
UnknownSolidDistillery, brewing+
(Cq: 31.4)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2570, [14]
16Food enzyme
alpha-amylase
UnknownSolidDistillery, brewing+
(Cq: 36.9)
GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2020.2572, [14]
17Food enzyme
alpha-amylase
Bacillus sp. LiquidDistillery, brewing+
(Cq: 25.1)
GM B. amyloliquefaciens producing alpha-amylase[4]
18Food enzyme
protease
Bacillus sp. SolidBaking+
(Cq: 43.8)
GM B. amyloliquefaciens producing proteaseRASFF2021.1641, [11,14]
19Feed additive
vitamin B2
UnknownSolidLivestock farming+
(Cq: 38.0)
No known GMM
Bacterial DNA
[4,12]
20Food enzyme
transglutaminase
UnknownSolidProtein processingNo known GMM
Bacterial DNA
[4]
21Food enzyme
transglutaminase
UnknownSolidProtein processingNo known GMM
Bacterial DNA
[4]
22Food enzyme
unknown
UnknownSolidBakingNo known GMM
Bacterial DNA
[4]
23Food enzyme
beta-glucosidase
Aspergillus nigerSolidDistillery, fruit processingNo known GMM
No bacterial DNA
[4]
24Food enzyme
alpha-amylase
UnknownLiquidDistillery, brewingNo known GMM
No bacterial DNA
[4]
25Food enzyme
rennet
Rhizomucor mieheiSolidDiary processingNo known GMM
No bacterial DNA
[4]
Table 5. Illustration of the reinforcement of the first-line screening analysis step using the BSG method. The full set of first-line screening methods (BSG, cat, tet-l, aadD and pUB110 methods) was applied on commercialized microbial fermentation products described in Table 4. Each sample was tested at a concentration of 10 ng in duplicate. The presence or absence of PCR amplification is symbolized by “+” or “−“, respectively. The results for the BSG method were generated in this study while the results for the other methods were previously generated.
Table 5. Illustration of the reinforcement of the first-line screening analysis step using the BSG method. The full set of first-line screening methods (BSG, cat, tet-l, aadD and pUB110 methods) was applied on commercialized microbial fermentation products described in Table 4. Each sample was tested at a concentration of 10 ng in duplicate. The presence or absence of PCR amplification is symbolized by “+” or “−“, respectively. The results for the BSG method were generated in this study while the results for the other methods were previously generated.
SamplesFirst-Line Screening MethodsReported GMM ContaminationsReferences
BSGcattet-laadDpUB110
2+++GM B. subtilis producing vitamin B2RASFF2018.2755, [9,12,14]
3+++GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,8,14]
4+++GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,10,14]
6++++GM B. velezensis producing protease
GM B. amyloliquefaciens producing alpha-amylase
RASFF2019.3332, [4,10,14]
19+/[4,12]
20+/[4]
22/[4]
25/[4]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Fraiture, M.-A.; Gobbo, A.; Papazova, N.; Roosens, N.H.C. Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in Fermentation Products. Fermentation 2022, 8, 78. https://doi.org/10.3390/fermentation8020078

AMA Style

Fraiture M-A, Gobbo A, Papazova N, Roosens NHC. Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in Fermentation Products. Fermentation. 2022; 8(2):78. https://doi.org/10.3390/fermentation8020078

Chicago/Turabian Style

Fraiture, Marie-Alice, Andrea Gobbo, Nina Papazova, and Nancy H. C. Roosens. 2022. "Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in Fermentation Products" Fermentation 8, no. 2: 78. https://doi.org/10.3390/fermentation8020078

APA Style

Fraiture, M. -A., Gobbo, A., Papazova, N., & Roosens, N. H. C. (2022). Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in Fermentation Products. Fermentation, 8(2), 78. https://doi.org/10.3390/fermentation8020078

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop